Population pharmacokinetic analysis of baicalin after oral administration of different Shuang-Huang-Lian formulations to rats

Zhang Guan-Min,Chen Wen-Qian,Li Liang,Hu Yu-Hui,Zhang Yan-Qing,Yi Hong,Yang Hua,Lu Wei
2008-01-01
Abstract:To investigate pharmacokinetics ofbaiealin after an oral administration of different Shuang-Huang-Lian (SHL) formulations to rats.Different SHL formulations were orally administered to rats.The concentrations of baicalin in rat plasma were determined by I-IPLC,the non-compartmental pharmacokinetic parameters and population pharmacokinetic parameters of baicalin were estimated by WinNoulin and NONMEM.The plasma concentration profiles of baicalin demonstrated double-peak phenomenon except for group microemulsion prescription 2.Population pharmacokinetic model developed includes four covariates,which were the effect of formulation (FORM) on CL/F and V/F,the effect of body weight (BW) on Ka,and the effect of gender (GEND) on V/F.Num-bers I to 6 denote SHL formulation decoction,oral liquid,colloidal solution,microemulsion prescription 1,mieroemulsion prescrip-tion 2 and granule,respectively.The equations for the parameters are as following:CL/F = (0.432 + 0.529).eηCL L / h if formulation was 2 or 6,otherwise CL/F = 0.432-eηCLL/h;V/F = (11.3-4.03-3.87 .GEND).eηCL L if formulation was 5,otherwise V/F = (11.3 - 3.87- GENT))- eηCL L;Ka = 0.475.[1 - 0.0223.(BW - 195.1)]- eηCL h-1.SHL formulations have significant effects on the pharmacokinetic parameters.
What problem does this paper attempt to address?